Health Sciences › Medicine › Oncologie › HER2/EGFR in Cancer Research

HER2/EGFR in Cancer Research

This cluster of papers focuses on the use of HER2-targeted therapies, such as trastuzumab and pertuzumab, in the treatment of HER2-positive breast cancer. It explores the mechanisms of action, resistance, and combination therapies involving chemotherapy and monoclonal antibodies. The cluster also delves into the role of EGFR, neuregulin 1, and ADAM metalloproteinases in HER2 signaling and breast cancer progression.

Questions & réponses

Aucune question publiée pour cette rubrique. Posez la première ci-dessous.